Astrazeneca (AZN)

 

Latest News

AZ expands lung cancer programme

AstraZeneca has issued an update on its immuno-oncology late-stage clinical development programme in first-line non-sm...

AZ 1st-line lung cancer immuno-oncology programme

RNS Number: 3289U AstraZeneca PLC 17 January 2017 17 January 2017 07:00 ASTRAZENECA EXPANDS 1ST-LINE LUNG CANCER IMMUNO-ONCOLOGY PROGRAMME OPPORTUNITIES Refined endpoints and statistical analysis plan in the Phase III MYSTIC trial China regulatory submission opportunity strengthened with the expansion of the Phase III NE...

Broker Forecast - JP Morgan Cazenove issues a broker note on AstraZeneca PLC

JP Morgan Cazenove today reaffirms its neutral investment rating on AstraZeneca PLC (LON:AZN) and cut its price targ...

Total Voting Rights

RNS Number: 2324T AstraZeneca PLC 03 January 2017 3 January 2017 16:00 Transparency Directive Voting Rights and Capital The following notification is made in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. On 31 December 2016 the issued share capital of AstraZeneca PLC with voting rights is 1,265,229,424 ordina...

All News

DateHeadlineSource
17-01-17AZ expands lung cancer programme StockMarketWire
17-01-17AZ 1st-line lung cancer immuno-oncology programmeRNS
04-01-17Broker Forecast - JP Morgan Cazenove issues a broker note on AstraZeneca PLCStockMarketWire
03-01-17Total Voting RightsRNS
03-01-17Chart of the week: New target for this stockInteractive Investor
23-12-16FTSE 100 flat as HSBC dragsStockMarketWire
23-12-16AstraZeneca completes sale of certain rights to Pfizer StockMarketWire
23-12-16Broker Forecast - Kepler Cheuvreux issues a broker note on AstraZeneca PLCStockMarketWire
23-12-16AZ COMPLETES SALE OF ANTIBIOTICS BUSINESSRNS
22-12-1610 most-bought funds of 2016Interactive Investor
19-12-16Look what Neil Woodford's just bought and soldInteractive Investor
19-12-16Broker Forecast - Jefferies International issues a broker note on AstraZeneca PLCStockMarketWire
19-12-16Broker Forecast - Jefferies International issues a broker note on AstraZeneca PLCStockMarketWire
16-12-16Director Deals - AstraZeneca PLC (AZN)StockMarketWire
16-12-16Director/PDMR ShareholdingRNS
09-12-16FTSE boosted by utilities, miners and M&AStockMarketWire
09-12-16FDA accepts AZ's durvalumab for BLA in bladder cancerStockMarketWire
09-12-16FDA accepts durvalumab for BLA in bladder cancerRNS
06-12-16Trial shows AZ's Tagrisso superiority over chemotherapy StockMarketWire
06-12-16Tagrisso data shows superiority over chemotherapyRNS
05-12-16FTSE mixed with blue chips up on miners StockMarketWire
05-12-16AZ completes agreement on Rhinocort Aqua rights StockMarketWire
05-12-16AZ completes agreement for Rhinocort Aqua rightsRNS
01-12-16Block listing Interim ReviewRNS
01-12-16Total Voting RightsRNS
30-11-16Floats, mergers and meltdowns: 21 years of the FTSE 100Interactive Investor
28-11-16Broker Forecast - JP Morgan Cazenove issues a broker note on AstraZeneca PLCStockMarketWire
25-11-16Is AstraZeneca plc or GlaxoSmithKline plc the best Black Friday buy?Motley Fool
22-11-16AZ head and neck cancer trials resume enrolmentStockMarketWire
22-11-16AZ head and neck cancer trials resume enrolmentRNS
17-11-16Here are Neil Woodford's latest tradesInteractive Investor
17-11-16Broker Forecast - Berenberg issues a broker note on AstraZeneca PLCStockMarketWire
17-11-16AZ completes out-licensing deal with AllerganStockMarketWire
15-11-16Broker Forecast - Deutsche Bank issues a broker note on AstraZeneca PLCStockMarketWire
14-11-16Shares rally as Trump goes softInteractive Investor
14-11-16Broker Forecast - Exane BNP Paribas issues a broker note on AstraZeneca PLCStockMarketWire
11-11-16Broker Forecast - Jefferies International issues a broker note on AstraZeneca PLCStockMarketWire
10-11-16AstraZeneca maintains guidance StockMarketWire
10-11-16Year-To-Date and Q3 2016 ResultsRNS
09-11-16It's Trump! So how come FTSE 100 hasn't crashed? Interactive Investor

RSS feeds

  • Editorial news feed for LSE:AZN Editorial
  • Regulatory news feed for LSE:AZN Regulatory